Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature.

cabozantinib immunotherapy radionecrosis (RN) radiosurgery stereotacic radiation

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 15 08 2023
accepted: 29 08 2023
medline: 4 10 2023
pubmed: 4 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fonc.2023.1136300.].

Identifiants

pubmed: 37790753
doi: 10.3389/fonc.2023.1278074
pmc: PMC10543421
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1278074

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2023 Lolli, Tessari, Berti, Fusella, Fiorentin, Bimbatti, Basso and Busato.

Auteurs

Jacopo Lolli (J)

Radiotherapy Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Francesca Tessari (F)

Radiotherapy Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Franco Berti (F)

Radiotherapy Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Marco Fusella (M)

Radiotherapy Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Department of Radiation Oncology, Abano Terme Hospital, Padua, Italy.

Davide Fiorentin (D)

Radiotherapy Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Department of Radiation Oncology, Abano Terme Hospital, Padua, Italy.

Davide Bimbatti (D)

Medical Oncology 1, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.

Umberto Basso (U)

Medical Oncology 1, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.

Fabio Busato (F)

Radiotherapy Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Department of Radiation Oncology, Abano Terme Hospital, Padua, Italy.

Classifications MeSH